Léo Berger

2.4k total citations
13 papers, 546 citations indexed

About

Léo Berger is a scholar working on Cellular and Molecular Neuroscience, Endocrinology, Diabetes and Metabolism and Psychiatry and Mental health. According to data from OpenAlex, Léo Berger has authored 13 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 3 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Psychiatry and Mental health. Recurrent topics in Léo Berger's work include Neuroscience and Neuropharmacology Research (3 papers), Neurological and metabolic disorders (3 papers) and Epilepsy research and treatment (2 papers). Léo Berger is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Neurological and metabolic disorders (3 papers) and Epilepsy research and treatment (2 papers). Léo Berger collaborates with scholars based in Canada, United States and Switzerland. Léo Berger's co-authors include A. M. Hakim, Jean-Martin Boulanger, Antoine M. Hakim, Serge Gauthier, Richard Leblanc, G Marchal, Mirko Dikšić, Alan C. Evans, Albert Gjedde and Sean Marrett and has published in prestigious journals such as Stroke, Journal of Medicinal Chemistry and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Léo Berger

12 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Léo Berger Canada 10 185 168 100 93 80 13 546
Ahmad Khaldi United States 14 175 0.9× 377 2.2× 81 0.8× 102 1.1× 44 0.6× 26 700
Anke M. Mans United States 15 152 0.8× 107 0.6× 199 2.0× 179 1.9× 104 1.3× 23 788
Torsten Ryman Sweden 12 170 0.9× 162 1.0× 56 0.6× 63 0.7× 8 0.1× 19 505
Signe T. Andersen Denmark 15 41 0.2× 269 1.6× 57 0.6× 216 2.3× 39 0.5× 29 919
Mary E. Maley United States 13 51 0.3× 122 0.7× 76 0.8× 156 1.7× 18 0.2× 14 769
Joseph Miller United States 12 113 0.6× 46 0.3× 46 0.5× 128 1.4× 22 0.3× 23 563
A. Schweitzer Switzerland 14 63 0.3× 50 0.3× 68 0.7× 77 0.8× 28 0.3× 28 684
A. Famulari Argentina 12 93 0.5× 84 0.5× 28 0.3× 76 0.8× 10 0.1× 24 479
Ge Tan China 14 106 0.6× 96 0.6× 39 0.4× 55 0.6× 22 0.3× 36 534
Ljiljana Lukić Serbia 11 124 0.7× 37 0.2× 78 0.8× 154 1.7× 51 0.6× 38 549

Countries citing papers authored by Léo Berger

Since Specialization
Citations

This map shows the geographic impact of Léo Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Léo Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Léo Berger more than expected).

Fields of papers citing papers by Léo Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Léo Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Léo Berger. The network helps show where Léo Berger may publish in the future.

Co-authorship network of co-authors of Léo Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Léo Berger. A scholar is included among the top collaborators of Léo Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Léo Berger. Léo Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Berger, Léo, Jérôme Rambaud, Julie Starck, et al.. (2023). Halogenated volatile anaesthetics for prolonged sedation in pediatric intensive care unit: first experience in two French pediatric intensive care units. SPIRE - Sciences Po Institutional REpository. 1(1).
2.
Boulanger, Jean-Martin, et al.. (2014). Left Atrium Dilatation and Multiple Vascular Territory Strokes. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 41(6). 704–708. 3 indexed citations
3.
Bocti, Christian, et al.. (2013). Vascular Cognitive Impairment: Most Useful Subtests of the Montreal Cognitive Assessment in Minor Stroke and Transient Ischemic Attack. Dementia and Geriatric Cognitive Disorders. 36(3-4). 154–162. 36 indexed citations
4.
Berger, Léo, et al.. (2012). Troponin Elevation Predicts Atrial Fibrillation in Patients with Stroke or Transient Ischemic Attack. Journal of Stroke and Cerebrovascular Diseases. 22(7). 978–983. 38 indexed citations
5.
Manchand, Percy S., et al.. (1994). Syntheses of Carprofen, a Carbazole-based Non-steroidal Anti-inflammatory Agent. Heterocycles. 39(2). 833–833. 9 indexed citations
6.
Hakim, A. M., Alan C. Evans, Léo Berger, et al.. (1989). The Effect of Nimodipine on the Evolution of Human Cerebral Infarction Studied by PET. Journal of Cerebral Blood Flow & Metabolism. 9(4). 523–534. 104 indexed citations
7.
Berger, Léo & Antoine M. Hakim. (1989). Nimodipine Prevents Hyperglycemia-Induced Cerebral Acidosis in Middle Cerebral Artery Occluded Rats. Journal of Cerebral Blood Flow & Metabolism. 9(1). 58–64. 25 indexed citations
8.
Berger, Léo & A. M. Hakim. (1988). Calcium channel blockers correct acidosis in ischemic rat brain without altering cerebral blood flow.. Stroke. 19(10). 1257–1261. 35 indexed citations
9.
Berger, Léo & A. M. Hakim. (1986). The association of hyperglycemia with cerebral edema in stroke.. Stroke. 17(5). 865–871. 149 indexed citations
10.
Berger, Léo, Serge Gauthier, & Richard Leblanc. (1985). Akinetic Mutism and Parkinsonism Associated with Obstructive Hydrocephalus. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 12(3). 255–258. 35 indexed citations
11.
Simon, Félix, et al.. (1981). Effect of the position of the phenolic group in morphinans on their affinity for oplate receptor binding. Life Sciences. 28(24). 2769–2772. 5 indexed citations
12.
Olson, Gary L., John F. Blount, L. Todaro, et al.. (1981). Dopamine receptor model and its application in the design of a new class of rigid pyrrolo[2,3-g]isoquinoline antipsychotics. Journal of Medicinal Chemistry. 24(9). 1026–1034. 53 indexed citations
13.
Rubio, F., et al.. (1980). Metabolism of carprofen, a nonsteroidal anti-inflammatory agent, in rats, dogs, and humans. Journal of Pharmaceutical Sciences. 69(11). 1245–1253. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmad Khaldi Breakdown of academic impact, for papers by Anke M. Mans Breakdown of academic impact, for papers by Torsten Ryman Breakdown of academic impact, for papers by Signe T. Andersen Breakdown of academic impact, for papers by Mary E. Maley Breakdown of academic impact, for papers by Joseph Miller Breakdown of academic impact, for papers by A. Schweitzer Breakdown of academic impact, for papers by A. Famulari Breakdown of academic impact, for papers by Ge Tan Breakdown of academic impact, for papers by Ljiljana Lukić
Rankless by CCL
2026